ARQT · Categories · Form 4

ARQT - SEC Form 4 insider transactions

Arcutis Biotherapeutics Inc. (ARQT) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for ARQT

• 19h
  Director Heron Patrick J was granted 5,778 shares, increasing direct ownership by 22% to 32,213 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 19h
  Director Lin Sue-Jean was granted 5,778 shares, increasing direct ownership by 22% to 32,513 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 19h
  Director Welgus Howard G. was granted 5,778 shares, increasing direct ownership by 18% to 38,378 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 19h
  Director Leonard Keith R was granted 5,778 shares, increasing direct ownership by 26% to 27,901 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 19h
  Director Curran Terrie was granted 5,778 shares, increasing direct ownership by 33% to 23,526 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 19h
  Director Munshi Amit was granted 5,778 shares, increasing direct ownership by 144% to 9,799 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 19h
  Director Krishnamohan Neha was granted 5,778 shares, increasing direct ownership by 26% to 27,901 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 19h
  Director Gilbert Halley E was granted 5,778 shares, increasing direct ownership by 26% to 27,901 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 27d
  SVP Chief Financial Officer Vairavan Latha sold $9,157 worth of shares (435 units at $21.05), decreasing direct ownership by 0.50% to 85,978 units (SEC Form 4) to cover withholding tax

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 27d
  Officer Burnett Patrick sold $4,673 worth of shares (222 units at $21.05), decreasing direct ownership by 0.18% to 120,244 units (SEC Form 4) (tax liability)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 34d
  Officer Matsuda Masaru sold $192,415 worth of shares (8,256 units at $23.31) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 126,689 units (SEC Form 4) to cover taxes

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 34d
  Officer Burnett Patrick sold $16,150 worth of shares (684 units at $23.61), decreasing direct ownership by 0.56% to 120,466 units (SEC Form 4) (withholding tax)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 34d
  SVP Chief Financial Officer Vairavan Latha sold $31,662 worth of shares (1,341 units at $23.61), decreasing direct ownership by 2% to 86,413 units (SEC Form 4) (tax liability)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 34d
  Officer Watanabe Todd sold $74,893 worth of shares (3,172 units at $23.61), decreasing direct ownership by 0.44% to 720,755 units (SEC Form 4) (for withholding tax)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 35d
  Director Welgus Howard G. sold $164,220 worth of shares (7,144 units at $22.99) as part of a pre-agreed trading plan, decreasing direct ownership by 18% to 32,600 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 67d
  SEC Form 4 filed by Welgus Howard G.

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 97d
  Director Leonard Keith R sold $997,195 worth of shares (39,272 units at $25.39) and exercised 39,272 shares at a strike of $8.28 (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 97d
  Director Welgus Howard G. sold $256,518 worth of shares (10,000 units at $25.65), decreasing direct ownership by 17% to 49,744 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 98d
  Officer Edwards Larry Todd was granted 30,000 shares and sold $92,846 worth of shares (3,687 units at $25.18), increasing direct ownership by 18% to 175,178 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 98d
  Officer Watanabe Todd was granted 102,000 shares and sold $940,528 worth of shares (37,349 units at $25.18), increasing direct ownership by 9% to 785,957 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 98d
  Officer Matsuda Masaru was granted 37,000 shares and sold $313,877 worth of shares (12,058 units at $26.03), increasing direct ownership by 24% to 136,932 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 98d
  SVP Chief Financial Officer Vairavan Latha was granted 27,000 shares and sold $71,844 worth of shares (2,853 units at $25.18), increasing direct ownership by 38% to 87,754 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 98d
  Officer Burnett Patrick was granted 46,750 shares and sold $158,320 worth of shares (6,287 units at $25.18), increasing direct ownership by 50% to 121,150 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 125d
  Officer Matsuda Masaru sold $1,027,293 worth of shares (40,638 units at $25.28), decreasing direct ownership by 27% to 110,003 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 125d
  Officer Burnett Patrick sold $346,455 worth of shares (13,469 units at $25.72), decreasing direct ownership by 14% to 80,651 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 125d
  Officer Watanabe Todd sold $505,710 worth of shares (19,833 units at $25.50), decreasing direct ownership by 3% to 721,306 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 125d
  SVP Chief Financial Officer Vairavan Latha sold $33,658 worth of shares (1,320 units at $25.50), decreasing direct ownership by 2% to 63,607 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 125d
  Director Welgus Howard G. sold $250,483 worth of shares (10,000 units at $25.05), decreasing direct ownership by 14% to 59,744 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 125d
  Officer Edwards Larry Todd sold $52,323 worth of shares (2,052 units at $25.50), decreasing direct ownership by 1% to 148,865 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 153d
  Officer Burnett Patrick sold $72,166 worth of shares (2,490 units at $28.98), decreasing direct ownership by 3% to 94,120 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 154d
  Director Welgus Howard G. sold $289,606 worth of shares (10,000 units at $28.96), decreasing direct ownership by 13% to 69,744 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 158d
  Officer Burnett Patrick sold $49,560 worth of shares (1,697 units at $29.20), decreasing direct ownership by 2% to 96,610 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 174d
  Officer Burnett Patrick exercised 11,500 shares at a strike of $3.64 and sold $332,851 worth of shares (11,500 units at $28.94) (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 183d
  Director Munshi Amit was granted 2,021 shares, increasing direct ownership by 101% to 4,021 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 188d
  Officer Matsuda Masaru sold $50,091 worth of shares (1,657 units at $30.23), decreasing direct ownership by 1% to 150,641 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 188d
  Director Welgus Howard G. sold $302,133 worth of shares (10,000 units at $30.21), decreasing direct ownership by 11% to 79,744 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 196d
  Director Lin Sue-Jean exercised 25,272 shares at a strike of $8.31 and sold $777,956 worth of shares (25,272 units at $30.78) (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 197d
  Officer Watanabe Todd sold $1,517,405 worth of shares (50,000 units at $30.35), decreasing direct ownership by 7% to 740,537 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 200d
  Officer Matsuda Masaru sold $72,135 worth of shares (2,550 units at $28.29), decreasing direct ownership by 2% to 151,476 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 200d
  Director Gilbert Halley E exercised 12,220 shares at a strike of $7.51 and sold $455,442 worth of shares (16,532 units at $27.55), decreasing direct ownership by 16% to 22,123 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 204d
  Director Krishnamohan Neha exercised 39,272 shares at a strike of $8.28 and sold $939,494 worth of shares (40,504 units at $23.20), decreasing direct ownership by 5% to 22,123 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 204d
  Director Leonard Keith R gifted 4,312 shares, decreasing direct ownership by 16% to 22,123 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 211d
  Officer Edwards Larry Todd sold $732,927 worth of shares (29,131 units at $25.16), decreasing direct ownership by 16% to 150,193 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 211d
  Officer Burnett Patrick exercised 17,250 shares at a strike of $3.64 and sold $417,145 worth of shares (17,250 units at $24.18) (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 216d
  Officer Burnett Patrick sold $156,449 worth of shares (6,486 units at $24.12), decreasing direct ownership by 6% to 98,325 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 216d
  Director Welgus Howard G. sold $252,669 worth of shares (10,000 units at $25.27), decreasing direct ownership by 10% to 89,744 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 216d
  SVP Chief Financial Officer Vairavan Latha sold $2,175 worth of shares (88 units at $24.72), decreasing direct ownership by 0.14% to 64,927 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 216d
  Officer Watanabe Todd sold $285,399 worth of shares (11,547 units at $24.72), decreasing direct ownership by 1% to 794,893 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 216d
  Officer Matsuda Masaru sold $178,156 worth of shares (7,208 units at $24.72), decreasing direct ownership by 4% to 154,026 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 222d
  Officer Watanabe Todd sold $1,001,032 worth of shares (40,000 units at $25.03), decreasing direct ownership by 5% to 806,440 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 247d
  Officer Edwards Larry Todd sold $90,263 worth of shares (4,504 units at $20.04), decreasing direct ownership by 2% to 179,324 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 249d
  Officer Watanabe Todd sold $884,649 worth of shares (45,000 units at $19.66), decreasing direct ownership by 5% to 846,440 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 249d
  Director Welgus Howard G. exercised 9,538 shares at a strike of $1.68 and sold $189,227 worth of shares (10,000 units at $18.92), decreasing direct ownership by 0.46% to 99,744 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 272d
  Officer Watanabe Todd sold $177,628 worth of shares (10,129 units at $17.54), decreasing direct ownership by 1% to 891,440 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 274d
  Officer Matsuda Masaru sold $583,716 worth of shares (36,130 units at $16.16), decreasing direct ownership by 18% to 161,234 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 278d
  Director Welgus Howard G. converted options into 10,000 shares and sold $156,383 worth of shares (10,000 units at $15.64) (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 292d
  Officer Burnett Patrick sold $66,250 worth of shares (4,188 units at $15.82), decreasing direct ownership by 4% to 104,811 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 301d
  Officer Burnett Patrick sold $53,988 worth of shares (3,847 units at $14.03), decreasing direct ownership by 3% to 108,999 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 308d
  Officer Watanabe Todd sold $165,429 worth of shares (11,547 units at $14.33), decreasing direct ownership by 1% to 901,569 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)
• 308d
  Officer Burnett Patrick sold $37,564 worth of shares (2,622 units at $14.33), decreasing direct ownership by 2% to 112,846 units (SEC Form 4)

  4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)

Other ARQT categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends